Micronucleus frequency in acquired middle ear cholesteatoma

Acta Oto-Laryngologica

Volumn 124, Issue 8, 2004, Pages 924-928

  Öztürk, Kayhan ^a   Yildirim, M Selman ^a   Acar, Hasan ^a   Arikoǧlu, Hilal ^a   Arbaǧ, Hamdi ^a   Ozer, Bedri ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Cholesteatoma; Complications; Micronucleus assay

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL AUDITORY CANAL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICRONUCLEUS TEST; PRIORITY JOURNAL; STANDARD; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHOLESTEATOMA, MIDDLE EAR; EAR, MIDDLE; FEMALE; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MIDDLE AGED; SKIN;

EID: 5644289557     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310016857     Document Type: Article

References (25)

1. Goh EK, Lee BJ, Wang SG, Chon KM, Kim CM. Expression of telomerase activity in cholesteatoma otitis media. Laryngol Otol 2001; 115: 881-4.
2. Chole RA, Choo MJ. Chronic otitis media, mastoiditis, and petrositis. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Richardson MA, Schuller DE, eds. Otolaryngology Head Neck Surgery. St Louis, MO: Mosby; 1998. p. 3026-46.
3. Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001: 111: 867-73.
4. Levenson MJ, Michaels L, Parisier SC. Congenital cholesteatomas of the middle ear in children: origin and management. Otolaryngol Clin North Am 1989; 22: 941-53.
5. Desloge RB, Carew JF, Finstad CL, Steiner MG, Sassoon J, Levenson MJ, et al. DNA analysis of human cholesteatomas. Am J Otol 1997; 18: 155-9.
6. Albino P, Kimmelman CP, Parisier SC. Cholesteatoma. A molecular and cellular puzzle. Am J Otol 1998; 19: 7-19.
7. Yildirim MS, Ozturk K, Acar H, Arbag H, Ulku CH. Choromosome 8 aneuploidy in acquired cholesteatoma. Acta Otolaryngol 2003; 123: 372-6.
8. Fenech M. Biomarkers of genetic damage for cancer epidemiology. Toxicology 2002; 181-2: 411-6.
9. Nath CJ, Ong T. Micronuclei assay in cytokinesis-blocked binucleated and conventional mononucleated methods in human peripheral lymphocytes. Teratog Carcinog Mutagen 1990; 10: 273-9.
10. Bukvic N, Susca F, Bukvic D, Fanelli M, Guanti G. 17-alpha- ethinylestradiol and norgestrel in combination induce micronucleus increases and aneuploidy in human lymphocyte and fibroblast cultures. Teratog Carcinog Mutagen 2000; 20: 147-59.
11. Torres de Lemos C, Erdtmann B. Cytogenetic evaluation of aquatic genotoxicity in human cultured lymphocytes. Mutat Res 2000; 467: 1-9.
12. Countryman PI, Heddle JA. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res 1976; 41: 321-32.
13. Bloching M, Hofmann A, Lautenschlager C, Berghaus A, Grummt T. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol 2000; 36: 550-5.
14. Garza CHL, Flores RMC, Elizondo EL, Gutierrez EIC. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat Res 2002; 515: 57-62.
15. Ren L, Yang J, Zhank H. Use of the cytokinesis block micronucleus method in mouse splenocytes. Mutat Res 1991; 262: 119-24.
16. Slonina D, Spekl K, Panteleeva A, Brankovic K, Hoinkis C, Dorr W. Induction of micronuclei in human fibroblasts and keratinocytes by 25 kV x-rays. Radiat Environ Biophys 2003; 42: 55-61.
17. Agrawal RC, Kumar S. Prevention of cyclophosphamide induced micronucleus formation in mouse bone marrow by indole-3-carbicol. Food Chem Toxicol 1998; 36: 975-7.
18. Miller AC, Brooks K, Stewart M, Anderson B, Shi L, McClain D, et al. Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation. J Environ Radioact 2003; 64: 247-59.
19. Ishibashi T, Shinogami M, Kaga K, Fukaya T. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Acta Otolaryngol (Stockh) 1997; 117: 714-8.
20. Hamzei M, Ventriglia G, Hagnia M, Antonopolous A, Bernal-Sprekelsen M, Dazert S, et al. Osteoclast stimulating and differentiating factors in human cholestea-toma. Laryngoscope 2003; 113: 436-42.
21. Lavezzi A, Mantovani M, Cazzulo A, Turconi P, Matturri L. Significance of trisomy 7 related to PCNA index in cholesteatoma. Am J Otolaryngol 1998; 19: 109-12.
22. Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998; 124: 261-4.
23. Herbold BA, Brendler-Schwaab SY, Ahr HJ. Ciprofloxacin: in vivo genotoxicity studies. Mutat Res 2001; 498: 193-205.
24. Schmausser B, Mueller SO, Eck M, Moller M, Muller-Hermelink H, Stopper H. Helicobacter pylori induces DNA damage in vitro. Cancer Lett 2001; 152: 145-9.
25. Aydemir N, Bilaloglu R. Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat Res 2003; 537: 43-51.